Skip to main content
. 2004 Jun;42(6):2501–2507. doi: 10.1128/JCM.42.6.2501-2507.2004

TABLE 2.

Nucleotide and amino acid changes within the omp1 sequence in conjunctival samples collected from remote communities in the Australian Northern Territory

Serovar
Nucleotide
Amino acid
Type %a No.b No. of changes Changec omp1 positiond No. of changes Changec MOMP positione
Ba 12.9 2 1 A → G 511 (VDII) 1 S → G 171
2 2 A → G 511 (VDII) 2 S → G 171
C → T 662 (CD) P → L 221
C 87.1 26 4 T → C 569 (CD) 3 I → T 190
A → G 571 (CD) N → D 191
G → A 972 (VDIV) Silent
G → T 1003 (VDIV) A → S 335
1 5 T → C 569 (CD) 4 I → T 190
A → G 571 (CD) N → D 191
A → G 697 (CD) N → D 233
G → A 972 (VDIV) Silent
G → T 1003 (VDIV) A → S 335
a

Percentage of 31 C. trachomatis PCR-amplified conjunctival samples with the indicated serovar.

b

Number of C. trachomatis samples having the same omp1 sequence changes as those indicated.

c

Nucleotide and amino acid changes from the most phylogenetically related reference strain (i.e., Ba/Apache-2 and C/TW-3/OT).

d

Nucleotide position from the start of the C. trachomatis omp1 gene at which the change was located.

e

Amino acid position from the start of the MOMP at which the deduced change has occurred.